MEDICAL RECOMMENDATIONS

Supplemental Statement - Afluria Tetra® - An Advisory Committee Statement (ACS)

National Advisory Committee on ImmunizationImmunization2018Official publication

ASEM documentary overview

Official National Advisory Committee on Immunization document (2018) on “Supplemental Statement - Afluria Tetra® - An Advisory Committee Statement (ACS)”. Supplemental Statement – Afluria® Tetra.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document

Related guidelines

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada